Home › Stocks › ASTH › All Fund Holders
ASTH — ASTRANA HEALTH INC · All Fund Holders
Funds holding (latest): 40 · Reported value held: $852.75M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 6.90M | $320.23M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 4.24M | $105.15M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 1.29M | $59.99M | 0.01% | Reduce |
| Geode Capital Management history | Q2 2026 | 1.17M | $54.22M | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 852.14K | $39.55M | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 685.92K | $31.83M | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 664.94K | $30.86M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 652.67K | $30.29M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 505.04K | $23.44M | 0.00% | Add |
| Royce & Associates history | Q2 2026 | 472.48K | $21.93M | 0.18% | Add |
| Morgan Stanley history | Q2 2026 | 433.51K | $20.12M | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 381.83K | $17.72M | 0.00% | Add |
| Goldman Sachs Group history | Q2 2026 | 271.80K | $12.61M | 0.00% | Reduce |
| Principal Global Investors history | Q2 2026 | 267.71K | $12.42M | 0.01% | Add |
| BNY Mellon history | Q2 2026 | 234.90K | $10.90M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 191.96K | $8.91M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 190.50K | $8.84M | 0.00% | Add |
| PSP Investments history | Q2 2026 | 179.75K | $8.34M | 0.02% | Add |
| Legal & General Investment Management America history | Q2 2026 | 98.15K | $4.56M | 0.00% | Reduce |
| D. E. Shaw & Co history | Q3 2025 | 145.56K | $4.13M | 0.00% | New |
| Renaissance Technologies history | Q2 2026 | 74.65K | $3.46M | 0.01% | Reduce |
| Marshall Wace history | Q4 2024 | 89.47K | $2.82M | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 58.07K | $2.69M | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2026 | 56.53K | $2.62M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 49.62K | $2.31M | 0.00% | New |
| Prudential Financial history | Q2 2026 | 44.96K | $2.09M | 0.00% | Add |
| Lazard Asset Management history | Q4 2025 | 74.28K | $1.84M | 0.00% | New |
| Point72 Asset Management history | Q3 2024 | 24.76K | $1.43M | 0.00% | Reduce |
| Balyasny Asset Management history | Q1 2026 | 58.45K | $1.43M | 0.00% | Reduce |
| Citigroup Inc history | Q2 2026 | 30.00K | $1.39M | 0.00% | Reduce |
| Bridgewater Associates history | Q3 2024 | 16.42K | $951.61K | 0.01% | Reduce |
| Manulife Financial history | Q2 2026 | 19.45K | $902.44K | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 17.63K | $818.12K | 0.00% | Reduce |
| Two Sigma Investments history | Q4 2025 | 30.71K | $761.99K | 0.00% | New |
| Janus Henderson Group history | Q1 2026 | 20.11K | $493.50K | 0.00% | Hold |
| Franklin Resources history | Q2 2026 | 7.67K | $356.01K | 0.00% | Reduce |
| CPP Investments history | Q2 2026 | 4.60K | $213.49K | 0.00% | New |
| PNC Financial Services history | Q2 2026 | 2.05K | $95.09K | 0.00% | Add |
| Amundi US history | Q3 2022 | 389 | $15.00K | 0.00% | Hold |
| T. Rowe Price Associates history | Q2 2026 | 62.16K | $2.88K | 0.00% | Add |